About

About Element Biosciences Element Biosciences is a multi-disciplinary startup founded in 2017 and focused on innovating genetic analysis tools for the research markets. Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity. Meet the Element AVITI™ System, a benchtop DNA sequencing platform with unprecedented performance, cost, and flexibility. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality. Check out our website today to learn more about AVITI with spec sheets, app notes, sequencing datasets and more. Please visit https://www.elementbiosciences.com/ for more information. Element Biosciences is advancing the future of drug discovery by enabling high-dimensional multiomic analysis through its next-generation AVITI24™ platform. Founded in 2017, Element is committed to empowering researchers with flexible, accessible, and high-performance sequencing technologies. The AVITI24 platform integrates genomic, transcriptomic, proteomic, and cytoprofiling data into a single workflow—delivering a comprehensive view of cellular systems at single-cell resolution. Powered by Element’s proprietary Avidite™ chemistry, AVITI24 offers exceptional data quality, cost efficiency, and scalability to accelerate biomarker discovery, target validation, and therapeutic development. With a mission to remove barriers to discovery, Element is helping scientists generate deeper insights into biology and uncover new possibilities for improving human health. Learn more at elementbiosciences.com